1. An update on current and emerging therapies for epithelial ovarian cancer: Focus on poly(adenosine diphosphate-ribose) polymerase inhibition and antiangiogenesis. (September 2017) Authors: Chung, Clement; Lee, Rosetta Journal: Journal of oncology pharmacy practice Issue: Volume 23:Number 6(2017) Page Start: 454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Current targeted therapies in lymphomas. (3rd October 2019) Authors: Chung, Clement Journal: American journal of health-system pharmacy Issue: Volume 76:Number 22(2019) Page Start: 1825 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?. Issue 9 (31st July 2017) Authors: Chung, Clement; Ma, Hilary Journal: Pharmacotherapy Issue: Volume 37:Issue 9(2017) Page Start: 1052 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level. (June 2020) Authors: Chung, Clement Journal: Journal of oncology pharmacy practice Issue: Volume 26:Number 4(2020) Page Start: 943 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. From oxygen sensing to angiogenesis: Targeting the hypoxia signaling pathway in metastatic kidney cancer. (5th October 2020) Authors: Chung, Clement Journal: American journal of health-system pharmacy Issue: Volume 77:Number 24(2020) Page Start: 2064 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ibrutinib, Obinutuzumab, Idelalisib, and Beyond: Review of Novel and Evolving Therapies for Chronic Lymphocytic Leukemia. Issue 12 (30th October 2014) Authors: Chung, Clement; Lee, Rosetta Journal: Pharmacotherapy Issue: Volume 34:Issue 12(2014) Page Start: 1298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Implementation of an integrated computerized prescriber order-entry system for chemotherapy in a multisite safety-net health system. (15th March 2018) Authors: Chung, Clement; Patel, Shital; Lee, Rosetta; Fu, Lily; Reilly, Sean; Ho, Tuyet; Lionetti, Jason; George, Michael D.; Taylor, Pam Journal: American journal of health-system pharmacy Issue: Volume 75:Number 6(2019) Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Instilling value, quality, and safety through hematology and oncology stewardship. (27th March 2019) Authors: Chung, Clement; Kim, Sara; Bubalo, Joseph Journal: American journal of health-system pharmacy Issue: Volume 76:Number 9(2019) Page Start: 617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Misconception on the duration of ado-trastuzumab emtansine treatment for HER2-positive early breast cancer. (11th January 2022) Authors: Chung, Clement Journal: American journal of health-system pharmacy Issue: Volume 79:Number 10(2022) Page Start: 717 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. New Therapeutic Targets and Treatment Options for Thrombotic Microangiopathy: Caplacizumab and Ravulizumab. Issue 3 (March 2021) Authors: Chung, Clement Journal: Annals of pharmacotherapy Issue: Volume 55:Issue 3(2021) Page Start: 330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗